0001209191-15-078220.txt : 20151103
0001209191-15-078220.hdr.sgml : 20151103
20151103212855
ACCESSION NUMBER: 0001209191-15-078220
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151026
FILED AS OF DATE: 20151103
DATE AS OF CHANGE: 20151103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lo Steven
CENTRAL INDEX KEY: 0001501959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 151195320
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94010
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-26
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001501959
Lo Steven
C/O CORCEPT THERAPEUTICS
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
VP Commercial Operations
Common stock
2015-11-02
4
S
0
12500
4.00
D
0
D
Common stock
2015-10-26
4
M
0
12500
3.29
A
12500
D
Stock option
3.29
2015-10-26
4
M
0
12500
3.29
A
2025-02-17
Common stock
12500
0
D
Exercise and hold.
Fully exerciseable.
31,499 shares were cancelled upon termination of employment.
/s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact
2015-11-03